2021
DOI: 10.1177/0956462420968998
|View full text |Cite
|
Sign up to set email alerts
|

Quantifying geographical diversity in sexually transmitted infections using population attributable risk: results from HIV prevention trials in South Africa

Abstract: In this study, we investigated spatial diversities of sexually transmitted infections (STIs) and quantified their impacts on the STIs using population attributable risk (PAR%). The study population was 7,557 women who participated in several HIV prevention trials from KwaZulu-Natal, South Africa. Our results provide compelling evidence for substantial geographical diversities on STI incidence rates in the region. Their population-level impacts on the STIs exceeded the combined impacts of the individual risk fa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 33 publications
(37 reference statements)
0
2
0
Order By: Relevance
“…Main studies including descriptions of the study populations are published elsewhere. 1823 Briefly, the inclusion criteria were similar across all the trials. They also used the similar HIV/STI testing methods.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Main studies including descriptions of the study populations are published elsewhere. 1823 Briefly, the inclusion criteria were similar across all the trials. They also used the similar HIV/STI testing methods.…”
Section: Methodsmentioning
confidence: 99%
“…Consistent with this priority, the current study aimed to quantify the association between HIV and STIs among women who participated in biomedical intervention trials and resided in KwaZulu-Natal, South Africa (2002–2016). 1823 We primarily focused on quantifying the impact of recurrent STIs on HIV acquisition using transition-specific models. In our modelling approach, recurrent STIs are assumed to be the clinical intermediate event(s) before the HIV infection (or censoring/end of study) which was considered as a ‘ terminating event’ .…”
Section: Introductionmentioning
confidence: 99%